GH Research PLC Accepted to ASCP Annual Meeting

Ticker: GHRS · Form: 6-K · Filed: May 15, 2025 · CIK: 1855129

Gh Research PLC 6-K Filing Summary
FieldDetail
CompanyGh Research PLC (GHRS)
Form Type6-K
Filed DateMay 15, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: conference-presentation, pipeline-update, pharmaceutical

TL;DR

GH Research PLC's pipeline presentations accepted for ASCP meeting May 27-30.

AI Summary

GH Research PLC announced on May 15, 2025, that its pharmaceutical pipeline presentations and late-breaking posters have been accepted at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting. The meeting is scheduled to occur from May 27-30, 2025, in Scottsdale, Arizona.

Why It Matters

Acceptance into the ASCP Annual Meeting signifies recognition of GH Research PLC's advancements in clinical psychopharmacology, potentially boosting investor confidence and highlighting the company's research progress.

Risk Assessment

Risk Level: low — This filing is an informational report about conference acceptance and does not contain significant financial or operational changes.

Key Players & Entities

FAQ

What specific pipeline presentations or posters were accepted by the ASCP?

The filing states that 'Pharmaceutical Pipeline Presentation and late-breaking posters' were accepted, but does not specify the exact titles or content of these presentations.

Where is the ASCP Annual Meeting being held?

The ASCP Annual Meeting is scheduled to take place in Scottsdale, Arizona.

When will the ASCP Annual Meeting take place?

The meeting is scheduled to take place from May 27-30, 2025.

What is the purpose of this Form 6-K filing?

This Form 6-K is a report of a foreign private issuer announcing the acceptance of its presentations at the ASCP Annual Meeting.

Does GH Research PLC file annual reports under Form 20-F or 40-F?

GH Research PLC indicates it files annual reports under cover of Form 20-F.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on May 15, 2025 regarding GH Research PLC (GHRS).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing